Infographic: The HBI Story
Get an overview of who HBI Solutions is, what we do and the difference our Spotlight Risk Management Solution can make for healthcare organizations today.

We help healthcare organizations manage risk and reduce costs with proven data science and a guided approach to make it simple.

EXPERTISE

GUIDANCE

DATA SCIENCE

REAL-TIME INSIGHTS
Our Spotlight Risk Management Solution aggregates and analyzes a wide range of data types from public, private and client sources.



We deliver predictive analytics that enable proactive risk management and real-time interventions for individuals and populations.

These predictions are based on ~100 billion feature combinations.
unstructured data?
HBI Spotlight uses uses natural language processing (NLP) to extract information from unstructured data sources, such as clinical notes and summaries.
This strengthens risk predictions and more quickly identifies patients in need of intervention when a diagnosis code is absent from the record.


Whether it’s predicting future costs, identifying an individual’s probability of a specific health event or condition, or understanding the risk profile of a population, HBI Solutions has the expertise.
More than 30 risk models are
available today, including:

Hospitalizations
Heart attack
Stroke

CONDITIONS
Hypertension
COPD

EVENTS
Sepsis
Mortality

Spotlight can be used by hospitals, health systems, physician practices, FQHCs, health plans, HIEs and ACOs. Right now, more than 20 million patients are receiving care through HBI-supported organizations.
When compared to the risk-adjusted state average, one health system realized the following benefits over a one-year period:

A recent study used Spotlight to analyze EMR data to identify Medicare patients at risk of chronic kidney disease in the next 12 months.

The study model identified
72.9% of high-risk patients at least three months before the confirmatory diagnosis was made by physicians.2

For a population of 50,000 lives, early interventions to prevent progression from Stage 2 to Stage 3 kidney disease could (using Medicare cost data) result in savings of $9.5M per year, and preventing progression to Stage 4 could save more than $104M.3
